Table of Contents
Future Strategies for Commercial Biocatalysis
Robert E. Speight and Karen T. Robins
Synthetic Approaches to Inhibitors of Isoprenoid Biosynthesis
Pedro Merino et al.
Using a Recombinant Metagenomic Lipase for Enantiomeric Separation of Pharmaceutically Important Drug Intermediates
Rakesh Kumar, Uttam Chand Banerjee, and Jagdeep Kaur
Biotechnological Production of Prenylated Xanthones for Pharmaceutical Use
Mariam Gaid et al.
Chemoenzymatic Approaches Towards (S)-Duloxetine
Danish Shahzad, Muhammad Faisal, and Aamer Saeed
Synthesis of Antioxidants via Biocatalysis
Salman Zafar
Biocatalysts: The Different Classes and Applications for Synthesis of APIs
Peter Grunwald
Laccase-Mediated Synthesis of Novel Antibiotics and Amino Acid Derivatives
Annett Mikolasch
Hydrolytic Enzymes for the Synthesis of Pharmaceuticals
Sergio González-Granda and Vicente Gotor-Fernández
Ene-Reductases in Pharmaceutical Chemistry
Katrin Hecht and Rebecca Buller
Biocatalyzed Synthesis of Antidiabetic Drugs
Andrés R. Alcántara
Glucose-Sensitive Drug Delivery Systems Based on Phenylboronic Acid for Diabetes Treatment
Li Zhao et al.
Synthesis of Important Chiral Building Blocks for Pharmaceuticals Using Lactobacillus and Rhodococcus Alcohol Dehydrogenases
Marion Rauter, Simon Krebs, Gotthard Kunze
Asymmetric Reduction of C=N Bonds by Imine Reductases and Reductive Aminases
Matthias Höhne, Philipp Matzel, and Martin Gand
Cipargamin: Biocatalysis in the Discovery and Development of an Antimalarial Drug
Thomas Rucha, Elina Siirola, and Radka Snajdrova
Halogenases with Potential Applications for the Synthesis of Halogenated Pharmaceuticals
Georgette Rebollar-Pérez et al.
Conversion of Natural Products from Renewable Resources in Pharmaceuticals by Cytochromes P450